Logo (Actavis) 435 (Lamotrigine Extended-Release 50 mg)
Pill with imprint Logo (Actavis) 435 is Gray, Round and has been identified as Lamotrigine Extended-Release 50 mg. It is supplied by Actavis Pharma, Inc.
Lamotrigine is used in the treatment of bipolar disorder; schizoaffective disorder; seizure prevention; epilepsy and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Logo (Actavis) 435


Lamotrigine Extended-Release
- Imprint
- Logo (Actavis) 435
- Strength
- 50 mg
- Color
- Gray
- Size
- 9.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Triazine anticonvulsants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Actavis Pharma, Inc.
- National Drug Code (NDC)
- 00228-1435
- Inactive Ingredients
-
hypromelloses,
lactose monohydrate,
magnesium stearate,
methacrylic acid - methyl methacrylate copolymer (1:2),
silicon dioxide,
magnesium silicate,
titanium dioxide,
triethyl citrate,
FD&C Blue No. 2,
FD&C Red No. 40,
FD&C Yellow No. 6,
triacetin
Note: Inactive ingredients may vary.
More about lamotrigine
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (1,538)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: triazine anticonvulsants
Patient resources
- Drug Information
- Lamotrigine (Advanced Reading)
- Lamotrigine Chewable Dispersible Tablets
- Lamotrigine Extended-Release Tablets
- Lamotrigine Orally Disintegrating Tablets
- Lamotrigine Tablets
- Other brands
- Lamictal, Lamictal XR, Subvenite, Lamictal CD, Lamictal ODT
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.